Blair Lab

Running, talking, breathing, remembering…

These things are coordinated by thousands of different proteins at work in our cells. Among them is a group of sentinels called chaperones that ensure the propriety of the majority of cellular proteins and resultant cellular functions. Our lab is focused on the role of chaperones in a group of more than 15 neurological degenerative diseases collectively termed “tauopathies”, the most common being Alzheimer’s disease. We hope that an understanding of chaperone function will enable therapeutic strategies that increase quality of life, halt disease progression and ultimately cure neurodegenerative diseases. 

Research Overview

Our lab is focused on preserving brain health through the regulation of the cell’s natural defense system, the molecular chaperone network. This network gets out of balance through aging and disease, which contribute to neuropsychiatric disorders like post-traumatic stress disorder (PTSD) and Alzheimer’s disease. Our group is systematically interrogating how specific chaperones preserve or destroy protein aggregates in Alzheimer’s disease and how the balance of one particular chaperone, FKBP51, impacts stress response for stress-related mental health disorders. In addition to expanding our knowledge about the biology and identifying targets, we are working to develop therapeutics to restore the balance through the regulation of molecular chaperones and therefore preserve brain health at the same time. We are confident that this strategy will yield tractable therapies to halt or possibly reverse Alzheimer’s disease progression as well as help reduce symptoms associated with PTSD and depression.

Learn more about our research

Laura Blair

PhD

Principal Investigator and Associate Professor

Meet the Team

Latest News

Featured Publications

  • Blair, Laura J, and Richard L Carpenter. (2026) 2026. “The 13th International Symposium on Heat Shock Proteins in Biology, Medicine, and the Environment: Honoring Legacy, Celebrating Scientific Advances, and Fostering Collaboration.”. Cell Stress & Chaperones 31 (2): 100147. https://doi.org/10.1016/j.cstres.2026.100147.

    The 13th International Symposium on Heat Shock Proteins in Biology, Medicine and the Environment, organized by the Cell Stress Society International (CSSI), was held in October 2025 in Syracuse, NY, and brought together investigators spanning basic, translational, and clinical stress biology. The meeting highlighted the continued evolution of the heat shock response from a canonical transcriptional program to a complex, multi-layered network integrating transcriptional condensates, posttranslational regulation of chaperones, spatial organization, and system-level stress adaptation. Scientific sessions showcased advances in stress-induced transcription and genome control, the expanding Hsp90/Hsp70 "chaperone code," proteostasis and protein quality control, mitochondrial chaperones and metabolic regulation, cancer-immune interfaces, host-pathogen interactions, and the roles of chaperones in aging and neurodegenerative disease. Particular emphasis was placed on emerging therapeutic and diagnostic strategies, including isoform-specific chaperone inhibitors, co-chaperone targeting, theranostic approaches, and clinical-stage candidates. Systems-level analyses of stress resilience, extracellular chaperone signaling, and organismal adaptation further underscored the breadth of stress biology across scales. The symposium also honored the legacy of Dr Len Neckers, whose pioneering contributions to Hsp90 biology shaped the field, and recognized outstanding scientific achievements through CSSI awards and fellowships. Collectively, the work presented reflects a field that continues to deepen mechanistic understanding while advancing toward precision-based therapeutic and diagnostic applications. This meeting report summarizes these developments and highlights future directions for stress biology research.

  • Hill, Shannon E, Priyanshi Parikh, Niat T Gebru, Sanam Banjade, Jennifer Guergues, Jessica Wohlfahrt, Stanley M Stevens, and Laura J Blair. (2026) 2026. “Dual Proximity-Based Interactome Mapping of FKBP51 and FKBP52 Uncovers Shared Metabolic Networks.”. Biochemical and Biophysical Research Communications 826: 153968. https://doi.org/10.1016/j.bbrc.2026.153968.

    The 51 kDa FK506-binding protein (FKBP51) has been studied for its involvement in regulating multiple biological systems, particularly as a regulator of steroid hormone receptors, but roles in metabolism, pain response, cell survival, protein turnover, autophagy, immune response, and insulin signaling have also been described. Genetic variants of FKBP51 are associated with various stress-related mental disorders. While recent research has clarified aspects of these processes, the complete range of FKBP51 interactions remains undetermined. FKBP52, a closely related homolog, also affects similar pathways. Recent studies have identified new protein partners for FKBP51 and FKBP52, suggesting an even broader interactome with transient associations. To further characterize interactions, TurboID-based proximity labeling was performed in HeLa cells. Proteomic analysis confirmed known FKBP51 and FKBP52 interactions, while also identifying additional shared and unique binding partners with strong enrichment in metabolic pathways, amino acid biosynthesis, and carbon metabolism. Although FKBP51 and FKBP52 proximal proteins were primarily cytosolic, FKBP51 showed additional associations with exosomal proteins while FKBP52 engaged with additional nuclear proteins. These findings highlight the overlapping roles in metabolic signaling and differentiate pathway-specific partners.